Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01887665 · ClinicalTrials.gov registry record · NA
Enhancing Early-Phase Care for Primary Care Patients With Unhealthy Substance Use
A NA study, sponsored by Brandeis University.
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT01887665: Completed NA study, sponsored by Brandeis University.
NCT01887665 is a NA study that has completed, run by Brandeis University. The registered enrollment target is 13 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01887665, a NA study, has completed, sponsored by Brandeis University.
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
The clinical trial portion of this study tests the hypothesis that contingency management-based incentives for primary care patients with substance use disorders to attend treatment services will increase treatment initiation and engagement. The investigators are investigating whether this approach that has been found effective in specialty treatment settings will work in the primary care context, in conjunction with screening.
Primary Outcome
Had initial outpatient treatment visit following positive screen and confirmatory diagnosis
Interventions
- BEHAVIORAL incentives
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2013-08 |
| Est. Completion | 2016-03 |
| Phase | NA |
What the finished NCT01887665 record still lists
NCT01887665 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which incentives is the first listed.
NCT01887665 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01887665 about?
NCT01887665 is a clinical study titled "Enhancing Early-Phase Care for Primary Care Patients With Unhealthy Substance Use". The clinical trial portion of this study tests the hypothesis that contingency management-based incentives for primary care patients with substance use disorders to attend treatment services will increase treatment initiation and engagement. The investigators are investigating whether this approach ...
What is the current status of trial NCT01887665?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2013-08. Estimated completion is 2016-03.
What interventions are being tested in trial NCT01887665?
The interventions under investigation include: incentives (BEHAVIORAL).
Who is sponsoring clinical trial NCT01887665?
This trial is sponsored by Brandeis University, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01887665's enrollment target sits among peer trials
13 1911th of 2000 higher than 88 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia